Aresko Pharma LLP - business services in New Delhi, Delhi, India. Directors, charges & compliance details.
LLPIN AAI-8146 Incorporated 10 March 2017 ROC Delhi HQ New Delhi, Delhi, India
Active Limited Liability Partnership business services
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
9 yrs
Est. 2017
Designated partners
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Delhi
ROC office
Incorporated
10 Mar 2017
Date of incorporation
Entity type
LLP
As registered with MCA

About Aresko Pharma LLP

Data last updated:

Aresko Pharma LLP is a limited liability partnership (LLP) based in New Delhi, Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 10 March 2017 and has been in existence for over 9 years.

The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAI-8146.

The LLP has a total obligation of contribution of β‚Ή1 Lakh. It is led by designated partners Rajpal Singh Kochhar and Kultaran Singh Kochhar.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Flat No. 11 First Floor Jorbagh Market, New Delhi, Delhi, India – 110003.

Company details

LLPIN AAI-8146
Incorporation Date 10 March 2017
Total Obligation of Contribution β‚Ή1 Lakh
ROC Delhi
Company Status Active

Contact details

Aresko Pharma LLP's registered office is in New Delhi, Delhi.

  • Registered Address
    Flat No. 11 First Floor Jorbagh Market, New Delhi, Delhi, India – 110003
  • Industry
    Business Services, Other Services
Comprehensive company report
Aresko Pharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Financials of Aresko Pharma LLP

FY 2025 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Aresko Pharma LLP, buy the company report.

Designated partners of Aresko Pharma LLP

Aresko Pharma has 2 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Rajpal Singh KochharDesignated Partner10 Mar 20179 Years 8 MonthsCurrent
Kultaran Singh KochharDesignated Partner28 Dec 20232 Years 10 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aresko Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Aresko Pharma LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Aresko Pharma LLP has 4 designated partner changes on record since 2017: 2 appointments and 2 cessations. The latest: Kultaran Singh Kochhar was appointed as Designated Partner on 28 Dec 2023.

AGM
Aresko Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Aresko Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Kultaran Singh Kochhar was appointed as Designated Partner.
Ceased
Jasbir Kaur Kochhar ceased to be Designated Partner.
Ceased
Prithipal Singh Kochhar ceased to be Designated Partner.
Appointed
Rajpal Singh Kochhar was appointed as Designated Partner.
Incorporation
10 Mar 2017
Aresko Pharma Llp was registered on 10 Mar 2017 with Roc Delhi I & aged 9 years 8 months as per MCA records.

Frequently asked questions

Aresko Pharma is an active limited liability partnership based in New Delhi, Delhi, India. The LLP works in other services, within the business services industry. It was incorporated on 10 March 2017 (9+ years old) and is registered under LLPIN AAI-8146.

Aresko Pharma has 2 current designated partners:

The latest financial statements of Aresko Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2017 are in the company report.

The LLPIN (Limited Liability Partnership Identification Number) of Aresko Pharma is AAI-8146. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Aresko Pharma was incorporated on 10 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.

Kultaran Singh Kochhar was appointed as Designated Partner on 28 Dec 2023. Jasbir Kaur Kochhar ceased to be Designated Partner on 31 Mar 2020. Prithipal Singh Kochhar ceased to be Designated Partner on 22 Mar 2017. Aresko Pharma has 4 designated partner changes on record in total.

The registered office of Aresko Pharma is at Flat No. 11 First Floor Jorbagh Market, New Delhi, Delhi, India – 110003.

Aresko Pharma operates in the business services industry, in the other services segment.

Aresko Pharma can be reached at its registered office: Flat No. 11 First Floor Jorbagh Market, New Delhi, Delhi, India – 110003.

Aresko Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.